The Impact of Physical Activity Intensity on the Dynamic Progression of Cardiometabolic Multimorbidity: Prospective Cohort Study Using UK Biobank Data

Background Although many studies have reported on the associations between the amount of physical activity (PA) and the transitions of cardiometabolic multimorbidity (CMM), the evidence for PA intensity has not been fully evaluated. Objective This study aimed to explore the impact of PA intensity on the dynamic progression of CMM. Methods The prospective cohort of this study using data from the UK Biobank included 359,773 participants aged 37-73 years who were recruited from 22 centers between 2006 and 2010. The diagnoses of CMM, which included the copresence of type 2 diabetes (T2D), ischemic heart disease, and stroke, were obtained from first occurrence fields provided by the UK Biobank, which included data from primary care, hospital inpatient record, self-reported medical condition, and death registers. The PA intensity was assessed by the proportion of vigorous PA (VPA) to moderate to vigorous PA (MVPA). Multistate models were used to evaluate the effect of PA intensity on the dynamic progression of CMM. The first model (model A) included 5 transitions, namely free of cardiometabolic disease (CMD) to first occurrence of CMD (FCMD), free of CMD to death, FCMD to CMM, FCMD to mortality, and CMM to mortality. The other model (model B) used specific CMD, namely T2D, ischemic heart disease, and stroke, instead of FCMD and included 11 transitions in this study. Results The mean age of the included participants (N=359,773) was 55.82 (SD 8.12) years at baseline, and 54.55% (196,271/359,773) of the participants were female. Compared with the participants with no VPA, participants with intensity levels of >0.75 to <1 for VPA to MVPA had a 13% and 27% lower risk of transition from free of CMD to FCMD (hazard ratio [HR] 0.87, 95% CI 0.83-0.91) and mortality (HR 0.73, 95% CI 0.66-0.79) in model A, respectively. The HR for the participants with no moderate PA was 0.82 (95% CI 0.73-0.92) compared with no VPA. There was a substantially protective effect of higher PA intensity on the transitions from free of CMD to T2D and from T2D to mortality, which reveals the importance of PA intensity for the transitions of T2D. More PA and greater intensity had a synergistic effect on decreasing the risk of the transitions from free of CMD to FCMD and mortality. Male participants, younger adults, adults with a higher BMI, current or previous smokers, and excessive alcohol drinkers could obtain more benefits from higher PA intensity for the lower risk of at least 1 transition from free of CMD, then to CMM, and finally to mortality. Conclusions This study suggests that higher PA intensity is an effective measure for preventing CMM and mortality in the early period of CMM development. Relevant interventions related to higher PA intensity should be conducted.

[1]  Jinchen Li,et al.  Association between healthy lifestyle and the occurrence of cardiometabolic multimorbidity in hypertensive patients: a prospective cohort study of UK Biobank , 2022, Cardiovascular Diabetology.

[2]  H. Kan,et al.  Long-term exposure to ambient air pollution is a risk factor for trajectory of cardiometabolic multimorbidity: A prospective study in the UK Biobank , 2022, EBioMedicine.

[3]  E. Stamatakis,et al.  Prospective Associations of Daily Step Counts and Intensity With Cancer and Cardiovascular Disease Incidence and Mortality and All-Cause Mortality , 2022, JAMA internal medicine.

[4]  Liu Yang,et al.  Shift Work and the Risk of Cardiometabolic Multimorbidity Among Patients With Hypertension: A Prospective Cohort Study of UK Biobank , 2022, Journal of the American Heart Association.

[5]  Jinchen Li,et al.  Associations between consumption of three types of beverages and risk of cardiometabolic multimorbidity in UK Biobank participants: a prospective cohort study , 2022, BMC Medicine.

[6]  E. Rimm,et al.  Long-Term Leisure-Time Physical Activity Intensity and All-Cause and Cause-Specific Mortality: A Prospective Cohort of US Adults , 2022, Circulation.

[7]  U. Ekelund,et al.  Physical activity, diet quality and all-cause cardiovascular disease and cancer mortality: a prospective study of 346 627 UK Biobank participants , 2022, British Journal of Sports Medicine.

[8]  Jinchen Li,et al.  Adherence to a healthy sleep pattern and incidence of cardiometabolic multimorbidity among hypertensive patients: a prospective study of UK Biobank , 2022, Sleep.

[9]  L. Fratiglioni,et al.  Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[10]  Chaofu Ke,et al.  Associations of handgrip strength with morbidity and all-cause mortality of cardiometabolic multimorbidity , 2022, BMC Medicine.

[11]  T. Littlejohns,et al.  Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study , 2022, The Lancet. Healthy longevity.

[12]  Xunjie Cheng,et al.  Trends in the Prevalence of Cardiometabolic Multimorbidity in the United States, 1999–2018 , 2022, International journal of environmental research and public health.

[13]  Kaipeng Wang,et al.  Patterns of cardiometabolic multimorbidity and the risk of depressive symptoms in a longitudinal cohort of middle-aged and older Chinese. , 2022, Journal of affective disorders.

[14]  K. Rahimi,et al.  Association between cardiometabolic disease multimorbidity and all-cause mortality in 2 million women and men registered in UK general practices , 2021, BMC Medicine.

[15]  R. Clarke,et al.  Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study , 2021, European heart journal.

[16]  S. Biddle,et al.  The prevalence of multimorbidity and its association with physical activity and sleep duration in middle aged and elderly adults: a longitudinal analysis from China , 2021, International Journal of Behavioral Nutrition and Physical Activity.

[17]  M. Bahls,et al.  Physical activity, sedentary behavior and risk of coronary artery disease, myocardial infarction and ischemic stroke: a two-sample Mendelian randomization study , 2021, Clinical Research in Cardiology.

[18]  G. Severi,et al.  Physical activity and stroke among women - A non-linear relationship. , 2021, Preventive medicine.

[19]  B. Campbell,et al.  Pre-stroke physical activity and admission stroke severity: A systematic review , 2021, International journal of stroke : official journal of the International Stroke Society.

[20]  A. Bauman,et al.  Is Cohort Representativeness Passé? Poststratified Associations of Lifestyle Risk Factors with Mortality in the UK Biobank , 2021, Epidemiology.

[21]  Yafeng Wang,et al.  Association of Physical Activity Intensity With Mortality: A National Cohort Study of 403 681 US Adults. , 2020, JAMA internal medicine.

[22]  A. Okely,et al.  Everything counts in sending the right message: science-based messaging implications from the 2020 WHO guidelines on physical activity and sedentary behaviour , 2020, International Journal of Behavioral Nutrition and Physical Activity.

[23]  R. Holman,et al.  Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II) , 2020, Cardiovascular Diabetology.

[24]  Paolo Vineis,et al.  Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study , 2020, BMC Medicine.

[25]  M. Hagströmer,et al.  Association between physical activity and all‐cause mortality: A 15‐year follow‐up using a compositional data analysis , 2019, Scandinavian journal of medicine & science in sports.

[26]  A. Grøntved,et al.  Association of high amounts of physical activity with mortality risk: a systematic review and meta-analysis , 2019, British Journal of Sports Medicine.

[27]  E. Stamatakis,et al.  Associations of vigorous physical activity with all-cause, cardiovascular and cancer mortality among 64 913 adults , 2019, BMJ Open Sport & Exercise Medicine.

[28]  A. Brodtmann,et al.  The Impact of Physical Activity Before and After Stroke on Stroke Risk and Recovery: a Narrative Review , 2019, Current Neurology and Neuroscience Reports.

[29]  Shengxu Li,et al.  Beneficial associations of low and large doses of leisure time physical activity with all-cause, cardiovascular disease and cancer mortality: a national cohort study of 88,140 US adults , 2019, British Journal of Sports Medicine.

[30]  A. Linke,et al.  Physical Activity in the Prevention and Treatment of Coronary Artery Disease , 2018, Journal of the American Heart Association.

[31]  H. Kolb,et al.  Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes , 2017, BMC Medicine.

[32]  G. Ellison,et al.  Robust causal inference using directed acyclic graphs: the R package 'dagitty'. , 2017, International journal of epidemiology.

[33]  James Woodcock,et al.  Physical activity and incident type 2 diabetes mellitus: a systematic review and dose–response meta-analysis of prospective cohort studies , 2016, Diabetologia.

[34]  O. Franco,et al.  Physical Activity Types and Coronary Heart Disease Risk in Middle-Aged and Elderly Persons: The Rotterdam Study. , 2016, American journal of epidemiology.

[35]  Samuel E. Jones,et al.  Height, body mass index, and socioeconomic status: mendelian randomisation study in UK Biobank , 2016, British Medical Journal.

[36]  Daniel F. Freitag,et al.  Association of Cardiometabolic Multimorbidity With Mortality. , 2015, JAMA.

[37]  L. Vatten,et al.  Physical activity and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis , 2015, European Journal of Epidemiology.

[38]  A. Bauman,et al.  Effect of Moderate to Vigorous Physical Activity on All-Cause Mortality in Middle-aged and Older Australians. , 2015, JAMA internal medicine.

[39]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[40]  Matthias Egger,et al.  Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. , 2011, International journal of epidemiology.

[41]  Hein Putter,et al.  mstate: An R Package for the Analysis of Competing Risks and Multi-State Models , 2011 .

[42]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[43]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[44]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.